Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2026 09:24 ET | Source: Research and Markets

Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche

Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The "Australia Regenerative Medicine Market - Distribution by Type of Products, Type of Therapeutic Area, End Users and Key Geographical Regions: Industry...
May 13, 2026 09:19 ET | Source: Research and Markets

Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo

Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The "Japan Regenerative Medicine Market - Distribution by Type of Product, Type of Therapeutic Area, End User and Key Geographical Regions: Industry Trends...
May 12, 2026 08:30 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands...
May 07, 2026 05:22 ET | Source: Research and Markets

MBA Strategic Thinking for Pharma and Biopharma Professionals | 2-Day Online Course: Sept 21-22, 2026 with 12 CPD Hours

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "MBA Strategic Thinking for Pharma and Biopharma Professionals (Sept 21st - Sept 22nd, 2026)" has been added to ResearchAndMarkets.com's offering. ...
April 30, 2026 08:30 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)

FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to...
April 23, 2026 08:30 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+...
April 20, 2026 06:44 ET | Source: Research and Markets

Healthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Filtration Market (Focus on Biologics Manufacturing): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Filtration, Type of...
April 16, 2026 08:30 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress

AGOURA HILLS, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a clinical-stage biopharmaceutical company developing drugs...
April 14, 2026 04:53 ET | Source: Research and Markets

Pharmaceuticals and Biopharmaceuticals Stability Testing Course: ICH Q1A-Q1F + ICH Q1E + ICH Q5C + EU/CPMP & WHO Guidelines and New ICH Q1 (Draft) (ONLINE EVENT: May 20th - May 22nd, 2026)

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Stability Testing of Pharmaceuticals and Biopharmaceuticals (May 20th - May 22nd, 2026)" training has been added to ResearchAndMarkets.com's...
April 14, 2026 04:25 ET | Source: Research and Markets

Modern Agile Leadership for Pharma and Biopharma Professionals: Adapting to a Changing Workplace - Practical Leadership Techniques to Maximise Team Performance (ONLINE EVENT: May 11th-12th, 2026)

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Modern Agile Leadership for Pharma and Biopharma Professionals: Adapting to a Changing Workplace (May 11th - May 12th, 2026)" training has been added...